Geneos Wealth Management Inc. Rx Sight, Inc. Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 17 shares of RXST stock, worth $526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17
Previous 19
10.53%
Holding current value
$526
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXST
# of Institutions
225Shares Held
32.2MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$121 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$74.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$70.8 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$54.1 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$36.2 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $856M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...